Calcium, vitamin D and PMS
This article was originally published in The Tan Sheet
Executive Summary
High intake of calcium and vitamin D may reduce the risk of premenstrual syndrome, Elizabeth Bertone-Johnson, University of Massachusetts, et. al. state in a case-control study published in the June 13 Archives of Internal Medicine. Female subjects with the highest intake of calcium and vitamin D exhibited relative risks of 0.59 and 0.70, respectively. The study was partially funded by GlaxoSmithKline, which launched a Tums Calcium for Life PMS formula based on research finding calcium supplementation reduced the occurrence and severity of premenstrual symptoms (1"The Tan Sheet" Jan. 15, 2001, p. 18). The efficacy of calcium and vitamin D supplementation in the prevention of incident PMS should be investigated in future large-scale clinical trials, the authors conclude...
You may also be interested in...
Tums Calcium For Life PMS, Bone Health Supplements Targeting Women
GlaxoSmithKline has expanded its Tums line to include two Calcium for Life supplements targeted at women: a PMS formula for the "physical and emotional" symptoms that accompany the condition and a Bone Health product.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.